NAICS Code 325412-15 - Medications Wholesale (Manufacturing)

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 11
Contact Emails: 23
Company Websites: 8
Phone Numbers: 8
Business Addresses: 11
Companies with Email: 5
Get Business List
NAICS CODE 325412-15
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead
Ideal for: Direct Mailing Email Campaigns Calling Market Research ‐ Free Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 325412 - Pharmaceutical Preparation Manufacturing - 1,726 companies, 213,574 emails.

NAICS Code 325412-15 Description (8-Digit)

Medications Wholesale (Manufacturing) is a subdivision of the Pharmaceutical Preparation Manufacturing industry that involves the production and distribution of medications in large quantities to various healthcare providers such as hospitals, clinics, and pharmacies. This industry is responsible for manufacturing and distributing a wide range of medications, including prescription drugs, over-the-counter medications, and generic drugs. The medications produced by this industry are used to treat a variety of medical conditions, ranging from common ailments like headaches and allergies to more serious illnesses like cancer and heart disease.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 325412 page

Tools

Tools commonly used in the Medications Wholesale (Manufacturing) industry for day-to-day tasks and operations.

  • High-performance liquid chromatography (HPLC)
  • Gas chromatography (GC)
  • Mass spectrometry (MS)
  • Ultraviolet-visible spectroscopy (UV-Vis)
  • Infrared spectroscopy (IR)
  • Nuclear magnetic resonance (NMR)
  • Particle size analyzer
  • Dissolution tester
  • Stability chambers
  • Moisture analyzer

Industry Examples of Medications Wholesale (Manufacturing)

Common products and services typical of NAICS Code 325412-15, illustrating the main business activities and contributions to the market.

  • Antibiotics
  • Antidepressants
  • Antihistamines
  • Antipsychotics
  • Blood pressure medications
  • Chemotherapy drugs
  • Diabetes medications
  • Pain relievers
  • Respiratory medications
  • Vaccines

History

A concise historical narrative of NAICS Code 325412-15 covering global milestones and recent developments within the United States.

  • The Medications Wholesale (Manufacturing) industry has a long history dating back to the early 20th century when the first pharmaceutical companies began to emerge. The industry has since undergone significant changes, with the introduction of new technologies and the development of new drugs. In the United States, the industry has seen a significant increase in demand for medications due to the aging population and the rise of chronic diseases. Notable advancements in the industry include the development of insulin in the 1920s, the introduction of antibiotics in the 1940s, and the discovery of new treatments for cancer and HIV in the 1980s and 1990s. Recent history of the Medications Wholesale (Manufacturing) industry in the United States has been marked by a number of significant events. In 2010, the Affordable Care Act was signed into law, which expanded access to healthcare and increased demand for medications. The industry has also seen a rise in the use of generic drugs, which has led to increased competition and lower prices. In addition, the industry has been impacted by the opioid epidemic, which has led to increased scrutiny of prescription drug use and sales. Overall, the industry has continued to grow and evolve, with new drugs and treatments being developed to meet the changing needs of patients.